jlp-2004
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 5, 2023 (NCT06169059)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tree pollenImmunity, desensitized
Tree pollen immunity, desensitized
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06431399 | Phase 1 | Apr 23, 2024 | Chonbuk National University, Jeil Pharmaceutical Co., Ltd. |
| NCT06169059 | Phase 1 | Oct 5, 2023 | Jeil Pharmaceutical Co., Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jeil Pharmaceutical Co., Ltd. | For profit | 2 | 2 | 1 | 2023 |
| Chonbuk National University | Academic/Hospital | 1 | 0 | 1 | 2024 |
2 organizations
Page 1 / 1